
Biosens builds portable point-of-care diagnostic tests that deliver lab-grade results rapidly to support faster clinical decisions. The company develops and commercializes biosensor-based POCT devices using graphene sensors, single-domain antibodies, CRISPR chemistry, and AI-driven signal analysis to replace legacy lateral-flow and central lab workflows. Biosens is a deeptech life sciences company that handles R&D, production, and commercialization of its hardware and consumables for healthcare providers and patients. Its platform targets hospital and outpatient diagnostics where faster results reduce length-of-stay and enable immediate actionable care.

Biosens builds portable point-of-care diagnostic tests that deliver lab-grade results rapidly to support faster clinical decisions. The company develops and commercializes biosensor-based POCT devices using graphene sensors, single-domain antibodies, CRISPR chemistry, and AI-driven signal analysis to replace legacy lateral-flow and central lab workflows. Biosens is a deeptech life sciences company that handles R&D, production, and commercialization of its hardware and consumables for healthcare providers and patients. Its platform targets hospital and outpatient diagnostics where faster results reduce length-of-stay and enable immediate actionable care.